Clare Peckitt

7.2k citations

102 papers · 3.9k indexed · 2 hit papers · h-index 31

Impact in

Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment
Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments

Papers in

Oncology 60
- Colorectal Cancer Treatments and Studies 30
- Colorectal Cancer Surgical Treatments 11
Cancer Research 23
- Cancer Genomics and Diagnostics 13

Co-authors: David Cunningham Ian Chau Andrew Wotherspoon Alicia Okines David González Naureen Starling Judith M. Bliss David Watkins
Journals: Journal of Clinical Oncology (23 papers)Annals of Oncology (15 papers)European Journal of Cancer (7 papers)Clinical Colorectal Cancer (5 papers)Radiotherapy and Oncology (4 papers)
Partner nations: United Kingdom Spain Sweden

In The Last Decade

Clare Peckitt

99 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Mismatch Repair Deficiency, Microsatellite Instability, and Survival 2017 · 365 citations

Peers

Countries citing papers authored by Clare Peckitt

Since Specialization

Citations

This map shows the geographic impact of Clare Peckitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Peckitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Peckitt more than expected).

Fields of papers citing papers by Clare Peckitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Peckitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Peckitt. The network helps show where Clare Peckitt may publish in the future.

Co-authors

The 25 scholars most cited alongside Clare Peckitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Clare Peckitt Line = papers co-authored together Clare Peckitt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C) BMC Cancer ·Susanna Slater, Annette Bryant, Hsiang-Chi Chen, Ruwaida Begum, Isma Rana, Maria Aresu, Clare Peckitt, Oleg Zhitkov, Retchel Lazaro-Alcausi, Victoria Borja, R J Powell, David Lowery, Michael Hubank, Thereasa A. Rich, Gayathri Anandappa, Ian Chau, Naureen Starling, David Cunningham	2023	20
2	R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial Annals of Hematology ·Andrea Kühnl, Clare Peckitt, Bijal Patel, Kirit M. Ardeshna, Marian Macheta, John Radford, Rod Johnson, Shankaranarayana Paneesha, Sarah Barton, Ian Chau, Ruwaida Begum, Nicola Valeri, Andrew Wotherspoon, Yong Du, Imene Zerizer, David Cunningham	2019	6
3	InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial Annals of Oncology ·Sheela Rao, Francesco Sclafani, Cathy Eng, Marianne G. Guren, Richard Adams, Al B. Benson, David Sebag‐Montefiore, Eva Segelov, Annette Bryant, Clare Peckitt, Arjun Roy, Michel Seymour, Jack Welch, Mark Saunders, R. Muirhead, John Bridgewater, Stephen Falk, Rob Glynne‐Jones, Dirk Arnold, David Cunningham	2018	16
4	Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy Clinical Cancer Research ·Elizabeth Smyth, Shenli Zhang, David Cunningham, Andrew Wotherspoon, Richie Soong, Clare Peckitt, Nicola Valeri, Matteo Fassan, Massimo Rugge, Alicia Okines, William Allum, Sally Stenning, Matthew Nankivell, Ruth E. Langley, Patrick Tan	2017	9
5	Rash, neutrophil-lymphocyte ratio (NLR) and survival in the REAL3 trial Annals of Oncology ·Elizabeth Smyth, Kyriakos Kouvelakis, Clare Peckitt, Thomas K. Waddell, Daniel W. Watkins, Saadiyah Rao, Naureen Starling, Claire Saffery, Alicia Okines, Ian Chau, David Cunningham	2017	1
6	Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study Clinical Colorectal Cancer ·Hamzeh Kayhanian, E. Goode, Francesco Sclafani, Joo Ern Ang, Marco Gerlinger, David González de Castro, Scott T.C. Shepherd, Clare Peckitt, Sheela Rao, David Watkins, Ian Chau, David Cunningham, Naureen Starling	2017	46
7	Multiplatform assay to classify formalin-fixed paraffin-embedded (FFPE) colorectal cancer (CRC) samples into molecular subtypes with mutational profiles Annals of Oncology ·Elisa Fontana, Chanthirika Ragulan, David Cunningham, Sanna Hulkki-Wilson, Francesco Sclafani, Gift Nyamundanda, Katherine Eason, Ruwaida Begum, Irene Chong, Clare Peckitt, Maria Antonietta Bali, J. Oates, David Watkins, Shuan Rao, Michael Hubank, Andrew Wotherspoon, Nicola Valeri, Ian Chau, Naureen Starling, Anguraj Sadanandam	2017	1
8	Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey Trials ·Sing Yu Moorcraft, Cheryl Marriott, Clare Peckitt, David Cunningham, Ian Chau, Naureen Starling, David Watkins, Sheela Rao	2016	140
9	PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer Annals of Oncology ·Francesco Sclafani, Gina Brown, David Cunningham, Andrew Wotherspoon, Diana Tait, Clare Peckitt, Jessica Evans, Shun Yu, Larissa Mendes, Josep Tabernero, Bengt Glimelius, Andrés Cervantes, Janet Thomas, Ruwaida Begum, J. Oates, Ian Chau	2016	54
10	A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory,KRASWild-Type, Metastatic Colorectal Cancer JNCI Journal of the National Cancer Institute ·Francesco Sclafani, Tae‐Yop Kim, David Cunningham, Tae W. Kim, Josep Tabernero, Hans‐Joachim Schmoll, Jae Kyung Roh, Sun Kim, Young Shin Park, Tormod Kyrre Guren, Eliza A. Hawkes, Steven Clarke, David Ferry, Jan‐Erik Frödin, Mark Ayers, Michael Nebozhyn, Clare Peckitt, Andrey Loboda, David J. Mauro, David Watkins	2015	73
11	145O Phase II study of AZD4547 in FGFR amplified tumours: gastroesophageal cancer (GC) cohort clinical and translational results Annals of Oncology ·Elizabeth Smyth, Nicholas C. Turner, Alex Pearson, Clare Peckitt, Ian Chau, David Watkins, Elaine Kilgour, Neil R. Smith, Angela Gillbanks, Sue Chua, Gina Brown, Rosalind Cutts, Claire Rooney, N. Tarazona Llavero, Anne Thomas, Sanjay Popat, David Cunningham	2015	2
12	Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001–2010 Gastric Cancer ·Elisa Fontana, Elizabeth Smyth, David Cunningham, Sheela Rao, David Watkins, William Allum, J N Thompson, Thomas K. Waddell, Clare Peckitt, Ian Chau, Naureen Starling	2015	8
13	TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial European Journal of Cancer ·Francesco Sclafani, D. González, David Cunningham, Sanna Hulkki Wilson, Clare Peckitt, Josep Tabernero, Bengt Glimelius, Andrés Cervantes, Gina Brown, Ian Chau	2013	5
14	Updated survival analysis of EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab in MRI-defined high risk rectal cancer patients European Journal of Cancer ·Francesco Sclafani, David Cunningham, Josep Tabernero, Bengt Glimelius, Andrés Cervantes, Clare Peckitt, D. Tait, Gina Brown, David González de Castro, Ian Chau	2013	3
15	Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial The Lancet Oncology ·Thomas K. Waddell, Ian Chau, David Cunningham, David González, Alicia Okines, Andrew Wotherspoon, Claire Saffery, Gary Middleton, Jonathan Wadsley, David Ferry, Wasat Mansoor, Tom Crosby, Fareeda Y. Coxon, David A. Smith, Justin S. Waters, Timothy Iveson, Stephen Falk, Sarah Slater, Clare Peckitt, Yolanda Barbáchano Hit paper breakdown →	2013	547
16	Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients Current Medical Research and Opinion ·Zenon Siergiejko, Ewa Świebocka, Nicola J. Smith, Clare Peckitt, Jo Leo, Guy Peachey, Robert Maykut	2011	61
17	The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study Journal of Thoracic Oncology ·Tom Treasure, David Waller, Carol Tan, James Entwisle, Mary Claire O’Brien, Kenneth J. O’Byrne, Gill Thomas, M. Snee, James Spicer, David Landau, Loı̈c Lang-Lazdunski, Judith M. Bliss, Clare Peckitt, Shaun Rogers, Erica Marriage, Gillian Coombes, Mark Webster-Smith, Julian Peto	2009	55
18	Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride British Journal of Radiology ·Charlotte Westbury, Alex Pearson, A Nerurkar, J. S. Reis-Filho, D Steele, Clare Peckitt, Grace Sharp, John Yarnold	2007	25
19	Relationship between aeroallergen and food allergen sensitization in childhood Clinical & Experimental Allergy ·Graham Roberts, Clare Peckitt, Kate Northstone, David P. Strachan, Gideon Lack, A. John Henderson, Jean Golding, (unknown)	2005	77
20	High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial Annals of Oncology ·R. Charles Coombes, Anthony Howell, Marie A. Emson, Clare Peckitt, C. Gallagher, Carmelo Bengala, A. Trés, R. Joel Welch, P.A. Lawton, R.D. Rubens, E. Woods, Joanne Haviland, David M. Vigushin, Edward Kanfer, Judith M. Bliss	2005	35

About Clare Peckitt

Clare Peckitt is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 102 papers that have together received 3.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (30 papers), Gastric Cancer Management and Outcomes (26 papers), Esophageal Cancer Research and Treatment (15 papers), Genetic factors in colorectal cancer (14 papers), Colorectal and Anal Carcinomas (14 papers), Cancer Genomics and Diagnostics (13 papers), Colorectal Cancer Surgical Treatments (11 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Gastroenterology (410 citations), Oncology (1.7k citations), Pulmonary and Respiratory Medicine (1.8k citations), Cancer Research (713 citations) and Pathology and Forensic Medicine (778 citations). Clare Peckitt has collaborated with scholars based in United Kingdom, Spain and Sweden. Frequent co-authors include David Cunningham, Ian Chau, Andrew Wotherspoon, Alicia Okines, David González, Naureen Starling, Judith M. Bliss, David Watkins, Diana Tait and Sheela Rao. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Clinical Colorectal Cancer and Radiotherapy and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact